drugset / Trial / NCT01743222
Intralymphatic eASC Administration in Healthy Volunteers
RandomizedSingle-groupSingle-blindTreatment
Summary
The objective is to determine the safety, tolerability and feasibility of the inguinal intralymphatic administration of expanded allogeneic adipose-derived stem cells (eASCs)
Timeline
- Start
- 2012-01
- Primary completion
- 2012-05
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | eASC | Cell therapy | 5e+06 cells | Other |
| Subject | eASC | Cell therapy | 1e+07 cells | Other |
Indications
No indication recorded.